2 weeks Ago By ABMN Staff
Sei Investments Co. lifted its position in ICU Medical, Inc. ( NASDAQ:ICUI – Free Report ) by 2.
7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,998 shares of the medical instruments supplier’s stock after purchasing an additional 883 shares during the period. Sei Investments Co.
owned about 0.14% of ICU Medical worth $5,276,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Several other institutional investors and hedge funds have also recently modified their holdings of the company.
Barclays PLC raised its holdings in ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock valued at $10,790,000 after acquiring an additional 8,010 shares during the period.
Principal Financial Group Inc. grew its position in shares of ICU Medical by 24.6% during the third quarter.
Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after purchasing an additional 25,031 shares in the last quarter. MetLife Investment Management LLC raised its stake in ICU Medical by 129.
1% during the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock valued at $2,258,000 after purchasing an additional 6,981 shares during the period. Jennison Associates LLC purchased a new position in ICU Medical in the 4th quarter worth approximately $556,000.
Finally, Geode Capital Management LLC boosted its stake in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after purchasing an additional 48,106 shares during the period.
96.10% of the stock is currently owned by institutional investors. Wall Street Analysts Forecast Growth Several equities research analysts have recently issued reports on ICUI shares.
StockNews.com cut shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Thursday, March 27th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.
00 price target on the stock in a report on Wednesday, December 11th. Finally, Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th.
Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $168.67.
ICU Medical Trading Down 0.8 % Shares of ICUI opened at $137.80 on Wednesday.
ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.
26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.
03 and a current ratio of 2.29. The company’s fifty day moving average is $153.
34 and its 200 day moving average is $163.24. The stock has a market capitalization of $3.
38 billion, a PE ratio of -30.15 and a beta of 0.73.
Insider Activity In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.
04. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,262,119.64.
The trade was a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link .
Corporate insiders own 6.70% of the company’s stock. ICU Medical Profile ( Free Report ) ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. Read More Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc.
( NASDAQ:ICUI – Free Report ). Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter .
.
